Found: 31
Select item for more details and to access through your institution.
Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 3089, doi. 10.3390/cancers16173089
- By:
- Publication type:
- Article
Author Correction to: Advances in anti-BRAF therapies for lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Advances in anti-BRAF therapies for lung cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 879, doi. 10.1007/s10637-021-01068-8
- By:
- Publication type:
- Article
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1133, doi. 10.1007/s10637-018-0653-2
- By:
- Publication type:
- Article
The prognostic value of PI3K mutational status in breast cancer: A meta‐analysis.
- Published in:
- Journal of Cellular Biochemistry, 2018, v. 119, n. 6, p. 4287, doi. 10.1002/jcb.26687
- By:
- Publication type:
- Article
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 293, doi. 10.3390/cells10020293
- By:
- Publication type:
- Article
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 4, p. 321, doi. 10.3390/cells8040321
- By:
- Publication type:
- Article
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer.
- Published in:
- Cells (2073-4409), 2018, v. 7, n. 7, p. 76, doi. 10.3390/cells7070076
- By:
- Publication type:
- Article
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis.
- Published in:
- Molecules, 2021, v. 26, n. 20, p. 6215, doi. 10.3390/molecules26206215
- By:
- Publication type:
- Article
Single nucleotide polymorphisms Rs1045642 C>T genetic alteration in ATP Binding Cassette Subfamily B Member 1 role in increasing everolimus toxicity in metastatic breast cancer.
- Published in:
- AIMS Molecular Science, 2020, v. 7, n. 1, p. 1, doi. 10.3934/molsci.2020001
- By:
- Publication type:
- Article
C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.1012112
- By:
- Publication type:
- Article
AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5515, doi. 10.3390/ijms22115515
- By:
- Publication type:
- Article
Mutant p53 as an Antigen in Cancer Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 4087, doi. 10.3390/ijms21114087
- By:
- Publication type:
- Article
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 2011, doi. 10.3390/ijms21062011
- By:
- Publication type:
- Article
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 2, p. 421, doi. 10.1007/s10549-020-05856-3
- By:
- Publication type:
- Article
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses.
- Published in:
- PLoS ONE, 2023, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0280364
- By:
- Publication type:
- Article
Corticosteroid switch after progression on abiraterone acetate plus prednisone.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 240, doi. 10.1007/s10147-019-01577-w
- By:
- Publication type:
- Article
Cancer management during the COVID-19 world pandemic.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3427, doi. 10.1007/s00262-023-03524-1
- By:
- Publication type:
- Article
The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00706-x
- By:
- Publication type:
- Article
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 311, doi. 10.3390/biomedicines11020311
- By:
- Publication type:
- Article
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1332939
- By:
- Publication type:
- Article
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4309, doi. 10.3390/cancers15174309
- By:
- Publication type:
- Article
The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment †.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5144, doi. 10.3390/cancers14205144
- By:
- Publication type:
- Article
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2952, doi. 10.3390/cancers14122952
- By:
- Publication type:
- Article
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2861, doi. 10.3390/cancers14122861
- By:
- Publication type:
- Article
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1440, doi. 10.3390/cancers13061440
- By:
- Publication type:
- Article
Early Changes of the Standardized Uptake Values (SUV max) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3314, doi. 10.3390/cancers12113314
- By:
- Publication type:
- Article
Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3293, doi. 10.3390/cancers12113293
- By:
- Publication type:
- Article
MR1-Restricted T Cells in Cancer Immunotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2145, doi. 10.3390/cancers12082145
- By:
- Publication type:
- Article
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0219566
- By:
- Publication type:
- Article
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes next.
- Published in:
- 2022
- By:
- Publication type:
- journal article